Testing effectiveness (Phase 2)Not Yet RecruitingNCT07348861
What this trial is testing
A Phase II Study of Neoadjuvant Sacituzumab Tirumotecan in Combination With Iparomlimab and Tuvonralimab in Locally Advanced Cervical Cancer
Who this might be right for
Cervical Cancer
Zheng Min 25